• ICR track cancer to ‘carbon date’ progression pharmafiles
    May 12, 2017
    The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease progression of a single patient with metastatic bowel cancer.
PharmaSources Customer Service